Election 2024 April 5, 2024 Topic Landing Page This topic page houses KFF resources that are relevant to policy debates in the 2024 elections, including those about abortion, the Affordable Care Act, and Medicare.
The Symbolic Manipulation of Health Issues in Elections March 15, 2024 From Drew Altman KFF President and CEO Drew Altman explains why data and facts, policy plans and lists of accomplishments do not connect with many voters. Understanding the symbolic dimensions of politics and issues is critical for experts. We can reach a share of the public with facts and data but need additional strategies to reach everyone, including storytelling and trusted messengers.
Experience of the Five Largest Publicly Traded Companies Operating Medicaid Managed Care Plans During Unwinding April 3, 2024 Issue Brief This brief takes a closer look at the five largest publicly traded companies (also referred to as “parent” firms) operating Medicaid MCOs, which account for half of Medicaid MCO enrollment nationally. This analysis presents the latest enrollment and financial data (through the end of 2023) as well as key takeaways from the firms’ unwinding experience.
Racial and Ethnic Disparities in Access to Medical Advancements and Technologies February 22, 2024 Issue Brief This brief provides an overview of diversity in clinical trials, disparities in access to novel drug therapies and other treatments, and the implications for health and health care.
It’s Not a Health Care Election, But Health Issues Might Still Add Up February 28, 2024 From Drew Altman In this column, KFF President and CEO Drew Altman explores the potential for some health care issues—including abortion, drug costs and other affordability challenges—to influence enough voters in swing states to make a difference in this year’s presidential election.
Upcoming SCOTUS Case Could Weaken the Impact of Regulation on Key Patient and Consumer Protections April 9, 2024 Issue Brief This brief discusses the longstanding legal doctrine, Chevron deference, being challenged in two cases before the U.S. Supreme Court and includes examples of what could be at stake for health care consumers should federal courts no longer use this doctrine to address litigation related to federal health regulations. The focus here is on patient and consumer protection regulation, but overturning the Chevron deference would have implications in all areas of health care.
Preventive Services Covered by Private Health Plans under the Affordable Care Act February 28, 2024 Fact Sheet Note: This content was updated on February 28, 2024 to incorporate new FAQs from CMS. Tables 1 and 2 were also updated to include updated recommendations. It has been more than ten years since the Affordable Care Act (ACA) required private insurance plans to cover recommended preventive services without any…
Commercialization of COVID-19 Vaccines, Treatments, and Tests: Implications for Access and Coverage February 6, 2024 Issue Brief With the depletion of the federal-purchased supply of COVID-19 vaccines, treatments and tests following the end of the public health emergency, this resource provides an overview of the implications of these changes for access to people covered by Medicare, Medicaid and private insurance, as well as those who are uninsured.
What to Watch in 2024: The Latest Health Cost and Affordability Issues and Trends January 24, 2024 News Release While issues of health care costs and affordability may not be at the forefront of this year’s election issues, they remain a major concern among the public. About a quarter of Americans say they or a family member struggled to pay their medical bills just in the past year, and…
10 Reasons Why Medicare Advantage Enrollment is Growing and Why It Matters January 30, 2024 Issue Brief This issue briefs lays out 10 reasons why Medicare Advantage enrollment has been growing and why we can expect more growth in the years to come.